Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium lactate + calcium chloride + magnesium chloride + sodium chloride + dextrose monohydrate is a sterile multi-electrolyte **peritoneal dialysis solution** supplied in varying dextrose strengths and electrolyte compositions. Dextrose monohydrate provides the osmotic gradient that promotes ultrafiltration of excess water across the peritoneal membrane, while sodium, calcium, magnesium, chloride, and lactate help maintain dialysate electrolyte composition and acid-base buffering. Delflex formulations are indicated for chronic kidney failure during peritoneal dialysis, while closely related Dianeal formulations are indicated for management of acute or chronic renal failure. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a98facd6-9daa-4d37-8209-63a0599dbfaa))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium lactate + calcium chloride + magnesium chloride + sodium chloride + dextrose monohydrate.